Collplant biotechnologies announces date for 2024 fourth quarter and full year 2024 financial results and conference call information

Conference call to be held on wednesday, march 26, 2025 at 10:00 a.m. u.s. est rehovot, israel , march 19, 2025 /prnewswire/ -- collplant biotechnologies (nasdaq:  clgn), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on wednesday, march 26, 2025, before the opening of the u.s. financial markets.
CLGN Ratings Summary
CLGN Quant Ranking